BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 28535496)

  • 1. The diagnostic challenge of low-grade ductal carcinoma in situ.
    Onega T; Weaver DL; Frederick PD; Allison KH; Tosteson ANA; Carney PA; Geller BM; Longton GM; Nelson HD; Oster NV; Pepe MS; Elmore JG
    Eur J Cancer; 2017 Jul; 80():39-47. PubMed ID: 28535496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic concordance among pathologists interpreting breast biopsy specimens.
    Elmore JG; Longton GM; Carney PA; Geller BM; Onega T; Tosteson AN; Nelson HD; Pepe MS; Allison KH; Schnitt SJ; O'Malley FP; Weaver DL
    JAMA; 2015 Mar; 313(11):1122-32. PubMed ID: 25781441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of 12 strategies for obtaining second opinions to improve interpretation of breast histopathology: simulation study.
    Elmore JG; Tosteson AN; Pepe MS; Longton GM; Nelson HD; Geller B; Carney PA; Onega T; Allison KH; Jackson SL; Weaver DL
    BMJ; 2016 Jun; 353():i3069. PubMed ID: 27334105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability in Pathologists' Interpretations of Individual Breast Biopsy Slides: A Population Perspective.
    Elmore JG; Nelson HD; Pepe MS; Longton GM; Tosteson AN; Geller B; Onega T; Carney PA; Jackson SL; Allison KH; Weaver DL
    Ann Intern Med; 2016 May; 164(10):649-55. PubMed ID: 26999810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Machine Learning of Breast Pathology Structures for Automated Differentiation of Breast Cancer and High-Risk Proliferative Lesions.
    Mercan E; Mehta S; Bartlett J; Shapiro LG; Weaver DL; Elmore JG
    JAMA Netw Open; 2019 Aug; 2(8):e198777. PubMed ID: 31397859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying and processing the gap between perceived and actual agreement in breast pathology interpretation.
    Carney PA; Allison KH; Oster NV; Frederick PD; Morgan TR; Geller BM; Weaver DL; Elmore JG
    Mod Pathol; 2016 Jul; 29(7):717-26. PubMed ID: 27056072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Reproducibility: What Happens When the Same Pathologist Interprets the Same Breast Biopsy Specimen at Two Points in Time?
    Jackson SL; Frederick PD; Pepe MS; Nelson HD; Weaver DL; Allison KH; Carney PA; Geller BM; Tosteson AN; Onega T; Elmore JG
    Ann Surg Oncol; 2017 May; 24(5):1234-1241. PubMed ID: 27913946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-Grade Ductal Carcinoma In Situ.
    Alghamdi SA; Krishnamurthy K; Garces Narvaez SA; Algashaamy KJ; Aoun J; Reis IM; Recine MA; Jorda M; Poppiti RJ; Gomez-Fernandez CR
    Am J Clin Pathol; 2020 Feb; 153(3):360-367. PubMed ID: 31769792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inter-observer variability between general pathologists and a specialist in breast pathology in the diagnosis of lobular neoplasia, columnar cell lesions, atypical ductal hyperplasia and ductal carcinoma in situ of the breast.
    Gomes DS; Porto SS; Balabram D; Gobbi H
    Diagn Pathol; 2014 Jun; 9():121. PubMed ID: 24948027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognizing breast ductal carcinoma in situ on fine-needle aspiration: a diagnostic dilemma.
    Guo HQ; Zhang ZH; Zhao H; Zhao LL; Pan QJ
    Diagn Cytopathol; 2013 Aug; 41(8):710-5. PubMed ID: 23729369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologists' agreement with experts and reproducibility of breast ductal carcinoma-in-situ classification schemes.
    Wells WA; Carney PA; Eliassen MS; Grove MR; Tosteson AN
    Am J Surg Pathol; 2000 May; 24(5):651-9. PubMed ID: 10800983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Influence of Disease Severity of Preceding Clinical Cases on Pathologists' Medical Decision Making.
    Frederick PD; Nelson HD; Carney PA; Brunyé TT; Allison KH; Weaver DL; Elmore JG
    Med Decis Making; 2017 Jan; 37(1):91-100. PubMed ID: 27037007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability in grading of ductal carcinoma in situ among an international group of pathologists.
    van Seijen M; Jóźwiak K; Pinder SE; Hall A; Krishnamurthy S; Thomas JS; Collins LC; Bijron J; Bart J; Cohen D; Ng W; Bouybayoune I; Stobart H; Hudecek J; Schaapveld M; Thompson A; Lips EH; Wesseling J;
    J Pathol Clin Res; 2021 May; 7(3):233-242. PubMed ID: 33620141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical Ductal Hyperplasia Bordering on Ductal Carcinoma In Situ.
    Tozbikian G; Brogi E; Vallejo CE; Giri D; Murray M; Catalano J; Olcese C; Van Zee KJ; Wen HY
    Int J Surg Pathol; 2017 Apr; 25(2):100-107. PubMed ID: 27481892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypia in breast pathology: what pathologists need to know.
    Katayama A; Toss MS; Parkin M; Ellis IO; Quinn C; Rakha EA
    Pathology; 2022 Feb; 54(1):20-31. PubMed ID: 34872753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep-learning model to improve histological grading and predict upstaging of atypical ductal hyperplasia / ductal carcinoma in situ on breast biopsy.
    Huang CY; Chang RF; Lin CY; Hsieh MS; Liao PC; Wang YJ; Kao YC; Porta L; Lin PY; Lee CC; Lee YH
    Histopathology; 2024 May; 84(6):983-1002. PubMed ID: 38288642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational pathology to discriminate benign from malignant intraductal proliferations of the breast.
    Dong F; Irshad H; Oh EY; Lerwill MF; Brachtel EF; Jones NC; Knoblauch NW; Montaser-Kouhsari L; Johnson NB; Rao LK; Faulkner-Jones B; Wilbur DC; Schnitt SJ; Beck AH
    PLoS One; 2014; 9(12):e114885. PubMed ID: 25490766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant inter- and intra-laboratory variation in grading of ductal carcinoma in situ of the breast: a nationwide study of 4901 patients in the Netherlands.
    van Dooijeweert C; van Diest PJ; Willems SM; Kuijpers CCHJ; Overbeek LIH; Deckers IAG
    Breast Cancer Res Treat; 2019 Apr; 174(2):479-488. PubMed ID: 30539380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interobserver reproducibility in the pathologic diagnosis of borderline ductal proliferative breast diseases].
    Wei B; Bu H; Zhu CR; Guo LX; Chen HJ; Zhao C; Zhang P; Chen DY; Tang Y; Jiang Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):849-53. PubMed ID: 15573772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grade of ductal carcinoma in situ accompanying infiltrating ductal carcinoma as an independent prognostic factor.
    Kim JY; Han W; Moon HG; Park IA; Ahn SK; Kim J; Lee JW; Kim T; Kim MK; Noh DY
    Clin Breast Cancer; 2013 Oct; 13(5):385-91. PubMed ID: 23870857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.